These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15753838)

  • 1. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation.
    Land WG
    Transplantation; 2005 Mar; 79(5):505-14. PubMed ID: 15753838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate alloimmunity: history and current knowledge.
    Land W
    Exp Clin Transplant; 2007 Jun; 5(1):575-84. PubMed ID: 17617046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
    Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
    J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of toll-like receptors signaling in organ transplantation.
    Li T; Chen G; Zhang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 36(12):1125-33. PubMed ID: 22246357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injury to allografts: innate immune pathways to acute and chronic rejection.
    Land WG
    Saudi J Kidney Dis Transpl; 2005; 16(4):520-39. PubMed ID: 18202507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and other links between innate and acquired alloimmunity.
    Goldstein DR
    Curr Opin Immunol; 2004 Oct; 16(5):538-44. PubMed ID: 15341996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation.
    Methe H; Zimmer E; Grimm C; Nabauer M; Koglin J
    Transplantation; 2004 Nov; 78(9):1324-31. PubMed ID: 15548971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor-4 and allograft responses.
    Samstein B; Johnson GB; Platt JL
    Transplantation; 2004 Feb; 77(3):475-7. PubMed ID: 14966433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
    Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
    Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of innate immunity in organ transplantation: part I: evolution of innate immunity and oxidative allograft injury.
    Land WG
    Transplant Rev (Orlando); 2012 Apr; 26(2):60-72. PubMed ID: 22000662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
    Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
    J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.
    Zhai Y; Shen XD; O'Connell R; Gao F; Lassman C; Busuttil RW; Cheng G; Kupiec-Weglinski JW
    J Immunol; 2004 Dec; 173(12):7115-9. PubMed ID: 15585830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity-mediated allograft rejection and strategies to prevent it.
    Land WG
    Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injury primes the innate immune system for enhanced Toll-like receptor reactivity.
    Paterson HM; Murphy TJ; Purcell EJ; Shelley O; Kriynovich SJ; Lien E; Mannick JA; Lederer JA
    J Immunol; 2003 Aug; 171(3):1473-83. PubMed ID: 12874240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of toll-like receptors in liver transplantation.
    Howell J; Gow P; Angus P; Visvanathan K
    Liver Transpl; 2014 Mar; 20(3):270-80. PubMed ID: 24243591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection.
    Goldstein DR; Tesar BM; Akira S; Lakkis FG
    J Clin Invest; 2003 May; 111(10):1571-8. PubMed ID: 12750407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immunity and organ transplantation: the potential role of toll-like receptors.
    Andrade CF; Waddell TK; Keshavjee S; Liu M
    Am J Transplant; 2005 May; 5(5):969-75. PubMed ID: 15816875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of Toll-like receptors in allogeneic islet transplantation.
    Ro H; Hong J; Kim BS; Lee EW; Kim MG; Han KH; Yeom HJ; Lee EM; Jeong JC; Oh KH; Ahn C; Yang J
    Transplantation; 2012 Nov; 94(10):1005-12. PubMed ID: 23169223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the innate immune system by the endogenous ligand hyaluronan.
    Shirali AC; Goldstein DR
    Curr Opin Organ Transplant; 2008 Feb; 13(1):20-5. PubMed ID: 18660702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.